SCHEMBL5097751

SCHEMBL5097751

COC(=O)C1(NC(=O)c2cc3ccccc3o2)CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.50
NPC1 O15118 7/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
TP53 P04637 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MAPT P10636 1/20 0.50
TSHR P16473 1/20 0.50
TAS1R3 Q7RTX0 3/20 0.49
TAS1R1 Q7RTX1 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1839850 0.89 RAB9A (0.53) RAB9ANPC1SMN1; SMN2TP53MAPT
SCHEMBL1840233 0.86 RAB9A (0.55) RAB9ANPC1SMN1; SMN2TP53L3MBTL1
SCHEMBL1837227 0.85 SMN1; SMN2 (0.50) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL5098450 0.79 RAB9A (0.51) RAB9ANPC1SMN1; SMN2TP53L3MBTL1
SCHEMBL5196554 0.77 PYGL (0.46) RAB9AL3MBTL1MAPTCYP2C9POLB
SCHEMBL5194411 0.77 PYGL (0.46) RAB9AL3MBTL1MAPTCYP2C9POLB
SCHEMBL5197354 0.77 PYGL (0.46) RAB9AL3MBTL1MAPTCYP2C9POLB
SCHEMBL5192234 0.77 PYGL (0.46) RAB9AL3MBTL1MAPTCYP2C9POLB
SCHEMBL2917926 0.76 NPC1 (0.48) RAB9ANPC1
SCHEMBL5104345 0.76 ALDH1A1 (0.47) RAB9ANPC1SMN1; SMN2TP53L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342027-B2 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2008-03-11 US disclosed
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof DONG-A PHARMACEUTICAL CO., LTD. (KR) 2005-10-20 US disclosed
WO-2004011457-A1 1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof CTRL, PRCP, CLPP RAB9A 2273/4885NPC1 729/4885SMN1; SMN2 4244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.